340B HEALTH BOARD ELECTS FOUR NEW MEMBERS
WASHINGTON, D.C., MAY 12, 2020— The Board of Directors of 340B Health has elected four new members representing hospitals and health systems participating in the 340B drug pricing program. The new members will serve a three-year term.
Karen L. Bowling is Vice President of Care Delivery and Transformation for WVU Medicine, headquartered in Morgantown, W.Va., and the President and CEO of Summersville Regional Medical Center and Braxton County Memorial Hospital. Prior to this position, she was Cabinet Secretary of the West Virginia Department of Health and Human Resources (DHHR), where she shepherded an expansion of the state’s Medicaid program. Before that, she held a variety of direct care and leadership positions in health care and education. Her career started as an emergency room nurse in a small rural hospital in Wyoming County.
Sandra F. Durley, PharmD, is Senior Associate Director of Ambulatory Care Pharmacy at University of Illinois Hospital & Health Sciences System (UI Health) in Chicago. In that position, she is responsible for coordinating the operations and finances of the system’s seven ambulatory care pharmacies. She has worked in various leadership roles for more than 25 years and has extensive ambulatory pharmacy operations experience in various areas, including 340B compliance and program optimization.
Patrick Gillies is the System Director of 340B Operations and Analytics at Common Spirit Health and is based in New Braunfels, Texas. In that position, he leads a large and diverse system that includes 77 covered entities participating in the 340B program. Prior to that, he served as Regional Administrator for Region VIII of the Health Resources and Services Administration, promoting national health initiatives, influencing national and state health care policy, and enhancing 340B program oversight. His previous experience includes leading community health for the Texas Department of State Health Services and administering a large integrated behavioral health delivery system in Austin, Texas.
Paul Mollo, PharmD, is the National Director for Medication Outcomes Disparity for Ascension and is based in Binghamton, N.Y. He oversees the system’s 340B program and patient medication assistance program at the national level and is the liaison to the ministry of the system’s Dispensary of Hope. Prior to that, he was the Director of Pharmacy for Our Lady of Lourdes Memorial Hospital in Binghamton, where he helped create and lead numerous programs to sustain community residents living with low incomes.
“We are pleased to have such knowledgeable, experienced, and capable additions to our board who will provide key guidance on the future of this organization,” said 340B Health President and CEO Maureen Testoni. “The importance of safety-net hospitals has come into sharper focus during the current public health emergency, and the input of these board members will be invaluable as we work to advocate for and provide resources to those hospitals and their patients.”
Testoni also thanked two departing long-time board members for their distinguished service. Mark Birdwhistell, the Vice President of External Affairs and Administration for the University of Kentucky/UK HealthCare, served 11 years on the board, including five years as Board Chair. Michael Bonck, Manager of Pharmaceutical Services at CHI Franciscan Health System, served 10 years on the board, including as chair of the Pharmacy Services Committee.
Contact: Richard Sorian at email@example.com or 202-536-2285.